Table 1.

Therapy options and final pathological responses. A/C, Adriamycin/Cytoxan; Ab, Abraxane; Cb, carboplatin; Av, bevacizumab; Tz, trastuzumab; T, Taxol.

		complete	non-complete
IDs	treat	pCR	pPR	pNR	total
1	A/C	0	1	0	1
2	A/C+Cb/T	4	3	3	10
3	A/C+Ab/Cb+Bz	3	3	4	10
4	A/C+Ab/Cb+Tz	2	2	0	4
5	Ab/Cb+Bz	0	2	3	5
6	Ab/Cb+Tz	2	0	2	4
7	Cb/T	0	0	2	2
	totals	11	11	14	N=36